Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
1961 1
1965 1
1966 2
1967 2
1969 3
1970 1
1971 3
1972 3
1973 1
1974 7
1975 3
1976 9
1977 1
1978 1
1979 9
1980 7
1981 9
1982 11
1983 9
1984 12
1985 11
1986 18
1987 28
1988 34
1989 26
1990 31
1991 31
1992 29
1993 35
1994 29
1995 31
1996 38
1997 40
1998 59
1999 52
2000 51
2001 64
2002 51
2003 62
2004 75
2005 106
2006 120
2007 153
2008 138
2009 143
2010 163
2011 206
2012 201
2013 241
2014 271
2015 272
2016 286
2017 307
2018 349
2019 350
2020 442
2021 504
2022 504
2023 556
2024 589
2025 427
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,391 results

Results by year

Filters applied: . Clear all
Page 1
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.
Liu X, Zhang Y, Yang KY, Zhang N, Jin F, Zou GR, Zhu XD, Xie FY, Liang XY, Li WF, He ZY, Chen NY, Hu WH, Wu HJ, Shi M, Zhou GQ, Mao YP, Guo R, Sun R, Huang J, Liang SQ, Wu WL, Su Z, Li L, Ai P, He YX, Zang J, Chen L, Lin L, Huang SH, Xu C, Lv JW, Li YQ, Hong SB, Jie YS, Li H, Huang SW, Liang YL, Wang YQ, Peng YL, Zhu JH, Zang SB, Liu SR, Lin QG, Li HJ, Tian L, Liu LZ, Zhao HY, Lin AH, Li JB, Liu N, Tang LL, Chen YP, Sun Y, Ma J. Liu X, et al. Among authors: lin ah. Lancet. 2024 Jun 22;403(10445):2720-2731. doi: 10.1016/S0140-6736(24)00594-4. Epub 2024 May 30. Lancet. 2024. PMID: 38824941 Clinical Trial.
Dry Eye Syndrome Preferred Practice Pattern®.
Amescua G, Ahmad S, Cheung AY, Choi DS, Jhanji V, Lin A, Mian SI, Rhee MK, Viriya ET, Mah FS, Varu DM; American Academy of Ophthalmology Preferred Practice Pattern Cornea/External Disease Panel. Amescua G, et al. Among authors: lin a. Ophthalmology. 2024 Apr;131(4):P1-P49. doi: 10.1016/j.ophtha.2023.12.041. Epub 2024 Feb 12. Ophthalmology. 2024. PMID: 38349301 No abstract available.
Precision-guided treatment in high-risk pediatric cancers.
Lau LMS, Khuong-Quang DA, Mayoh C, Wong M, Barahona P, Ajuyah P, Senapati A, Nagabushan S, Sherstyuk A, Altekoester AK, Fuentes-Bolanos NA, Yeung V, Sullivan A, Omer N, Diamond Y, Jessop S, Battaglia L, Zhukova N, Cui L, Lin A, Gifford AJ, Fleuren EDG, Dalla-Pozza L, Moore AS, Khaw SL, Eisenstat DD, Gottardo NG, Wood PJ, Tapp H, Alvaro F, McCowage G, Nicholls W, Hansford JR, Manoharan N, Kotecha RS, Mateos MK, Lock RB, Tyrrell V, Haber M, Trahair TN, Cowley MJ, Ekert PG, Marshall GM, Ziegler DS. Lau LMS, et al. Among authors: lin a. Nat Med. 2024 Jul;30(7):1913-1922. doi: 10.1038/s41591-024-03044-0. Epub 2024 Jun 6. Nat Med. 2024. PMID: 38844796 Free PMC article.
Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial.
Wu X, Liu J, Wang J, Wang L, Lin Z, Wang X, Zhu J, Kong B, Fei J, Tang Y, Xia B, Liang Z, Wang K, Huang Y, Zheng H, Lin A, Jiang K, Wang W, Wang X, Lou G, Pan H, Yao S, Li G, Hao M, Cai Y, Chen X, Yang Z, Chen Y, Wen H, Qu P, Xu C, Hsieh CY; FLAMES Investigators. Wu X, et al. Among authors: lin a. Nat Med. 2024 Jun;30(6):1612-1621. doi: 10.1038/s41591-024-03003-9. Epub 2024 May 15. Nat Med. 2024. PMID: 38750351 Clinical Trial.
Radiotherapy toxicities: mechanisms, management, and future directions.
Verginadis II, Citrin DE, Ky B, Feigenberg SJ, Georgakilas AG, Hill-Kayser CE, Koumenis C, Maity A, Bradley JD, Lin A. Verginadis II, et al. Among authors: lin a. Lancet. 2025 Jan 25;405(10475):338-352. doi: 10.1016/S0140-6736(24)02319-5. Epub 2025 Jan 16. Lancet. 2025. PMID: 39827884 Review.
Application repetition and electrode-tissue contact result in deeper lesions using a pulsed-field ablation circular variable loop catheter.
Di Biase L, Marazzato J, Gomez T, Byun E, Zou F, Grupposo V, Mohanty S, La Fazia VM, Ammirati G, Lin A, Garcia DY, Della Rocca D, Al Ahamad A, Schiavone M, Gasperetti A, Freilich M, Serna JC, Forleo G, Liu X, Lakkireddy D, Tondo C, Natale A, Zhang XD. Di Biase L, et al. Among authors: lin a. Europace. 2024 Aug 30;26(9):euae220. doi: 10.1093/europace/euae220. Europace. 2024. PMID: 39150065 Free PMC article.
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS Lymphoma.
Grommes C, Nandakumar S, Schaff LR, Gavrilovic I, Kaley TJ, Nolan CP, Stone J, Thomas AA, Tang SS, Wolfe J, Bozza A, Wongchai V, Hyde A, Barrett E, Lynch EA, Madzsar JT, Lin A, Piotrowski AF, Pentsova E, Francis JH, Hatzoglou V, Schultz N, Reiner AS, Panageas KS, DeAngelis LM, Mellinghoff IK. Grommes C, et al. Among authors: lin a. Clin Cancer Res. 2024 Sep 13;30(18):4005-4015. doi: 10.1158/1078-0432.CCR-24-0605. Clin Cancer Res. 2024. PMID: 38995739 Free PMC article. Clinical Trial.
6,391 results